Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Nov 17, 2023 6:15pm
193 Views
Post# 35742093

RE:RE:RE:RE:RE:RE:Information void

RE:RE:RE:RE:RE:RE:Information voidInteresting perspective,  DJDawg.   I'll take 1.5M at this point.  My estimate of burn rate was $1.5M per Qtr inclusive of the laser div.  That one doesn't seem to be paying for itself, IMO.  So maybe they need to divert all funds to getting this BTD done.   The least I expect to hear with the next NR is if there are new dependencies for pre-BTD, like the central lab validation and how long will it take.  If history repeats, we'll be playing guessing games here after the next NR.   This is the closest the company has gotten to the brink since I started owning shares. BTD or bust. Oh, another good thing. We won't hear JV mentioned for a while either.       
DJDawg wrote: I think that the 1.5 million is not a coincidence. The other company that I saw that did this (LIFE switched into PP) just converted all the LIFE buyers into the PP as the pricepoint was the same.

So my bet is that raise total will be 1.5m.

If monthly burn is 400k (my notes) and they have 1m from before that means that can roll 6m.

That will cover BTD which I believe will be succesful.

So overall, I'm not worried about cash situation for the near term.

Yaaaaaaaaaay. We are good to gooooooo (said in the least enthusiastic way possible)


<< Previous
Bullboard Posts
Next >>